Biological Age Study of Chicken Essence

The goal of this clinical trial is to evaluate the effects of BRAND'S Essence of Chicken (BEC) on biological age. Biological age will be measured using epigenetic clocks \[DunedinPACE (primary), GrimAge, PhenoAge, etc\] and other relevant tools. Participants will take BEC or a placebo every day for 1 year. Biological age measures will be taken at baseline and after 1 year.

Inclusion criteria 1. Healthy participants aged 35 to 45 years 2. Must not participate in other clinical studies Exclusion Criteria 1. A history of allergy to Essence of Chicken or any ingredients of Investigational product (IP) 2. An evidence or history of clinically significant diseases within the last 5 years 3. Body Mass Index ≥ 30 kg/m2 4. Any laboratory test or clinical signs and symptoms greater than grade 1 of NCI CTCAE grading. 5. Has clinically significant abnormalities in laboratory test results under investigator judgement. 6. Has other severe acute or chronic medical or psychiatric conditions or laboratory abnormality 7. Concurrent pharmacological treatments or use of cannabis-containing products. 8. Any recent drastic changes in lifestyle (diet, exercise, smoking pattern, sleep habits and supplement intake) in the last 4 weeks. 9. Judgment by the investigator that the participant should not participate in the study, for instance if the participant is unlikely to comply with all study procedures or if the participant is unlikely to be in good health throughout the study. 10. Regular consumption of any Essence of Chicken, defined as \> 2 bottles a week of consumption in the past 6 months. 11. Heavy smokers consume 7 or more standard packs per week. 12. Heavy drinkers consuming 15 or more standard drinks per week. 13. Individuals with poor sleep habits (i.e. allocate less than 4 hours of sleep per night) 14. Women who are pregnant or lactating or has a plan to become pregnant during study period. 15. Woman who has menopausal status, underwent oophorectomy and has to receive hormonal replacement therapy. 16. Have undergone surgery within 3 weeks prior to screening 17. Current enrolment in another interventional study or refusal to refrain from participating in another interventional study during the study period.